Evidence for use of glatiramer acetate in multiple sclerosis

Lancet Neurol. 2005 Feb;4(2):75-6; discussion 76-7. doi: 10.1016/S1474-4422(05)00975-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Glatiramer Acetate
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Meta-Analysis as Topic
  • Multiple Sclerosis / drug therapy*
  • Peptides / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Peptides
  • Glatiramer Acetate